Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Corebridge Financial Appoints Hirotaka Inoue to Board

Corebridge Financial elected Hirotaka Inoue to its board of directors effective April 21, 2026, filling the seat of Minoru Kimura, who will depart the board effective April 20.

Inoue is currently executive officer and head of regulatory and market intelligence, global business planning, at Nippon Life Insurance. Corebridge said he will serve as a Nippon Life-designated director.

The appointment follows a board change of one director out and one director in, with the transition taking place over consecutive days in April. Corebridge said Inoue brings experience in global insurance regulation, financial risk oversight and monetary policy.

At Nippon Life, Inoue monitors global regulatory developments and advises senior management on strategic implications for the company’s international insurance operations. Before that, he held senior leadership roles at the Bank of Japan covering monetary policy, financial markets and international financial policy, and also served at the Financial Stability Board secretariat.

Corebridge said it had more than $385 billion in assets under management and administration as of Dec. 31, 2025. Following these announcements, the company's shares moved 0.99%, and are now trading at a price of $24.41. For the full picture, make sure to review Corebridge Financial's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS